ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2018 American Transplant Congress

    Effect of Everolimus with Reduced Calcineurin Inhibitor on Efficacy and Safety in De Novo Kidney Transplant Recipients: 12-Month Results from the US Cohort of TRANSFORM Study

    S. Mulgaonkar,1 Y. Qazi,1 D. Kim,1 V. Peddi,1 K. McCague,2 D. Patel,2 A. Wiseman.1

    1TRANSFORM Study Group, Livingston; 2Novartis Pharmaceuticals Corporation, East Hanover.

    Purpose: Despite remarkable short-term survival benefits, long-term outcomes in kidney transplant recipients (KTRs) remain unsatisfactory. Everolimus (EVR) may improve long-term outcomes by reducing calcineurin inhibitor…
  • 2018 American Transplant Congress

    Molecular Profiling of the Injury-Repair Response in Early Subclinical Inflammation

    M. Seifert, D. Della Manna, X. Liu, F. Rosenblum, M. Yanik, E. Yang, J. Pollock, R. Mannon.

    UAB School of Medicine, Birmingham.

    Purpose: Surveillance biopsies can detect subclinical T-cell mediated rejection (SC-TCMR) or subclinical borderline rejection (SC-B-TCMR) in kidney transplants with normal/stable creatinine. Some consider SC-B-TCMR to…
  • 2018 American Transplant Congress

    Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry

    S. Sanoff,1 K. Ravindra,1 W. Irish.1,2

    1Duke University Medical Center, Durham, NC; 2CTI Consulting, Raleigh, NC.

    Introduction:Belatacept (BEL) was FDA approved for Kidney Transplantation (KTx) June 2011. It has largely been evaluated in two controlled trials (N Engl J Med 2016;374:333-43).…
  • 2018 American Transplant Congress

    Evolving Etiologies for Readmissions and Their Impact on Graft Survival in Kidney Transplantation

    D. Taber, N. Pilch, Z. Su, C. Mardis, J. Fleming, N. Patel, H. Meadows, P. Mauldin, V. Rao, D. Dubay.

    MUSC, Charleston, SC.

    Background: Although readmissions after kidney transplant are a well-known risk factor for graft loss, it is unclear if certain etiologies are associated with poorer outcomes…
  • 2018 American Transplant Congress

    Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times

    A. Narra,1 L. Strasfeld,2 D. Basuli,1 M. Stack,1 E. Langewisch,3 A. Olyaei,1 D. Norman,1,4 J. Lockridge.1,4

    1Transplant Nephrology, Oregon Health and Science University, Portland, OR; 2Infectious Diseases, OHSU, Portland, OR; 3Transplant Nephrology, University of Nebraska Medical Center, Omaha, NE; 4Transplant Nephrology, Portland VA, Portland, OR.

    Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in kidney transplant recipients.A pre-transplant allocation strategy by matching deceased kidney donors and recipients…
  • 2018 American Transplant Congress

    Clinical and Pathological Findings in Hepatitis C Positive Renal Transplant Recipients Following Alemtuzumab Induction

    S. Jonchhe, J. Husson, A. Haririan, B. Ravichandran.

    University of Maryland Medical Center, Baltimore.

    BackgroundHistorically, renal transplant recipients (RTRs) with chronic hepatitis C (HCV) have worse long-term outcomes. Induction with alemtuzumab (ALM) in HCV positive RTRs has been postulated…
  • 2018 American Transplant Congress

    Impact of Pre-Transplant Dialysis on ESRD-Free and Patient Survival in Heart Transplant Alone and in Simultaneous Heart/Kidney Transplant Recipients: UNOS Data Analysis

    S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.

    Medicine, Loyola University, Maywood, IL.

    It is well known that chronic kidney disease has significant negative impact on post-transplant survival in heart transplant (HTx) recipients. Here we wanted to evaluate…
  • 2018 American Transplant Congress

    Screening Coccidioides Serology in Kidney Transplant Recipients: A 10-Year Cross-Sectional Analysis

    K. Phonphok,1 T. Duong,1 N. Datta,1 O. Beaird,2 J. Shaenman,2 S. Bunnapradist.1

    1Medicine-Nephrology, UCLA, Los Angeles, CA; 2Medicine-Infectious Diseases, UCLA, Los Angeles, CA.

    Introduction: Southern California is one of the endemic areas of coccidioidomycosis and patients receiving immunosuppression including kidney transplant recipients are at higher risk for dissemination…
  • 2018 American Transplant Congress

    A Follow-Up Report on the Use of IVIG+Rituximab to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly-Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

    R. Najjar, E. Huang, A. Vo, J. Choi, K. Lim, S. Louie, A. Peng, S. Sethi, M. Toyoda, X. Zhang, S. Jordan.

    Medicine/Nephrology, Cedars Sinai Medical Center, Los Angeles, CA.

    Introduction: Desensitization (DES) with IVIG/rituximab is associated with a reduction in donor specific antibodies (DSA), improved transplant rates and outcomes in highly-sensitized (HS) patients. We…
  • 2018 American Transplant Congress

    Impact of the Differences between Body Mass Index of Recipient and Donor in a Population of Robotic Kidney Transplant

    K. Tulla,1 I. Tzvetanov,1 C. Di Bella,1 F. Gheza,1 M. Spaggiari,1 J. Oberholzer,2 E. Benedetti.1

    1Surgery, University of Illinois, Chicago, IL; 2Surgery, Universit of Virginia, Virginia, VA.

    Introduction: The recent introduction of minimally invasive technique allows to perform kidney transplant in otherwise suitable recipients regardless the recipient BMI. This could lead to…
  • « Previous Page
  • 1
  • …
  • 310
  • 311
  • 312
  • 313
  • 314
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences